Featured image for “Early Detection of Melanoma Can Make All the Difference”
05/16/2024

Early Detection of Melanoma Can Make All the Difference

…ones by learning the ABCDEs of melanoma. The Critical Importance of Early Detection of Melanoma In 2024, the statistics around…
Blog - Melanoma360
Featured image for “Global Advocacy: Progress Report”
11/13/2018

Global Advocacy: Progress Report

Melanoma is a global disease. In the United States, one person dies every 54 minutes from melanoma. Australia and New…
Blog - Melanoma360
Breaking News
Featured image for “May is Melanoma Awareness Month”
04/30/2021

May is Melanoma Awareness Month

…and thrive. Despite melanoma. Regardless of melanoma. Beyond melanoma. We worked in conjunction with our international advocates on this campaign,…
Blog - Melanoma360
Featured image for “Q&A with Omid Hamid, MD, Director of the Melanoma Center and Phase I Immuno-Oncology Program at The Angeles Clinic and Research Institute”
04/27/2018

Q&A with Omid Hamid, MD, Director of the Melanoma Center and Phase I Immuno-Oncology Program at The Angeles Clinic and Research Institute

…How would a collaborative melanoma tissue bank consortium help advance the prevention, detection, and treatment of melanoma? A collaborative melanoma tissue…
Blog - Melanoma360
Melanoma Research
Featured image for “Six-and-a-Half-Year Outcomes for Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Continue to Demonstrate Durable Long-Term Survival Benefits in Patients with Advanced Melanoma”
05/21/2021

Six-and-a-Half-Year Outcomes for Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Continue to Demonstrate Durable Long-Term Survival Benefits in Patients with Advanced Melanoma

…safety. About Melanoma Melanoma is a form of skin cancer characterized by the uncontrolled growth of pigment-producing cells (melanocytes) located…
Blog - Melanoma360
Breaking News
Melanoma Research
Featured image for “Castle Biosciences Awarded U.S. Federal Supply Schedule Contract for DecisionDx-Melanoma”
08/25/2021

Castle Biosciences Awarded U.S. Federal Supply Schedule Contract for DecisionDx-Melanoma

…plans that incorporate DecisionDx-Melanoma test results. Through June 30, 2021, DecisionDx-Melanoma has been ordered 78,277 times for use in patients…
Blog - Melanoma360
Breaking News
Melanoma Research
Featured image for “World Health Organization Predicts Half a Million With Melanoma in 2040”
06/13/2024

World Health Organization Predicts Half a Million With Melanoma in 2040

Without intervention today, the number of people affected by melanoma will skyrocket. The World Health Organization warns that new diagnoses…
Blog - Melanoma360
Featured image for “In Plain English: Tumor-Infiltrating Lymphocyte (“TIL”) Therapy for Advanced Melanoma”
11/16/2022

In Plain English: Tumor-Infiltrating Lymphocyte (“TIL”) Therapy for Advanced Melanoma

By Kim Margolin, M.D., FACP, FASCO Background—Immunotherapy of melanoma The explosion of immunotherapy over the past decade has revolutionized the…
Blog - Melanoma360
In Plain English
Featured image for “In Plain English—June 2021 News from ASCO, the American Society of Clinical Oncology”
07/29/2021

In Plain English—June 2021 News from ASCO, the American Society of Clinical Oncology

…great potential in combination with nivolumab and to be most effective as the first treatment of metastatic melanoma. This study…
Blog - Melanoma360
In Plain English
Featured image for “AIM at Melanoma Opens the Second Branch of Fresh Frozen Primary Tissue Bank at Sutter’s California Pacific Medical Center”
09/09/2019

AIM at Melanoma Opens the Second Branch of Fresh Frozen Primary Tissue Bank at Sutter’s California Pacific Medical Center

…for melanoma while improving the lives of those it affects. AIM’s global research initiatives include The International Melanoma Tissue Bank…
Blog - Melanoma360
Breaking News
Melanoma Research

Early Detection of Melanoma Can Make All the Difference

…ones by learning the ABCDEs of melanoma. The Critical Importance of Early Detection of Melanoma In 2024, the statistics around…
Featured image for “Early Detection of Melanoma Can Make All the Difference”
Blog - Melanoma360

Global Advocacy: Progress Report

Melanoma is a global disease. In the United States, one person dies every 54 minutes from melanoma. Australia and New…
Featured image for “Global Advocacy: Progress Report”
Blog - Melanoma360
Breaking News

May is Melanoma Awareness Month

…and thrive. Despite melanoma. Regardless of melanoma. Beyond melanoma. We worked in conjunction with our international advocates on this campaign,…
Featured image for “May is Melanoma Awareness Month”
Blog - Melanoma360

Q&A with Omid Hamid, MD, Director of the Melanoma Center and Phase I Immuno-Oncology Program at The Angeles Clinic and Research Institute

…How would a collaborative melanoma tissue bank consortium help advance the prevention, detection, and treatment of melanoma? A collaborative melanoma tissue…
Featured image for “Q&A with Omid Hamid, MD, Director of the Melanoma Center and Phase I Immuno-Oncology Program at The Angeles Clinic and Research Institute”
Blog - Melanoma360
Melanoma Research

Six-and-a-Half-Year Outcomes for Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Continue to Demonstrate Durable Long-Term Survival Benefits in Patients with Advanced Melanoma

…safety. About Melanoma Melanoma is a form of skin cancer characterized by the uncontrolled growth of pigment-producing cells (melanocytes) located…
Featured image for “Six-and-a-Half-Year Outcomes for Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Continue to Demonstrate Durable Long-Term Survival Benefits in Patients with Advanced Melanoma”
Blog - Melanoma360
Breaking News
Melanoma Research

Castle Biosciences Awarded U.S. Federal Supply Schedule Contract for DecisionDx-Melanoma

…plans that incorporate DecisionDx-Melanoma test results. Through June 30, 2021, DecisionDx-Melanoma has been ordered 78,277 times for use in patients…
Featured image for “Castle Biosciences Awarded U.S. Federal Supply Schedule Contract for DecisionDx-Melanoma”
Blog - Melanoma360
Breaking News
Melanoma Research

World Health Organization Predicts Half a Million With Melanoma in 2040

Without intervention today, the number of people affected by melanoma will skyrocket. The World Health Organization warns that new diagnoses…
Featured image for “World Health Organization Predicts Half a Million With Melanoma in 2040”
Blog - Melanoma360

In Plain English: Tumor-Infiltrating Lymphocyte (“TIL”) Therapy for Advanced Melanoma

By Kim Margolin, M.D., FACP, FASCO Background—Immunotherapy of melanoma The explosion of immunotherapy over the past decade has revolutionized the…
Featured image for “In Plain English: Tumor-Infiltrating Lymphocyte (“TIL”) Therapy for Advanced Melanoma”
Blog - Melanoma360
In Plain English

In Plain English—June 2021 News from ASCO, the American Society of Clinical Oncology

…great potential in combination with nivolumab and to be most effective as the first treatment of metastatic melanoma. This study…
Featured image for “In Plain English—June 2021 News from ASCO, the American Society of Clinical Oncology”
Blog - Melanoma360
In Plain English

AIM at Melanoma Opens the Second Branch of Fresh Frozen Primary Tissue Bank at Sutter’s California Pacific Medical Center

…for melanoma while improving the lives of those it affects. AIM’s global research initiatives include The International Melanoma Tissue Bank…
Featured image for “AIM at Melanoma Opens the Second Branch of Fresh Frozen Primary Tissue Bank at Sutter’s California Pacific Medical Center”
Blog - Melanoma360
Breaking News
Melanoma Research